Chemoinformaics analysis of (-)-Maalioxide
Molecular Weight | 222.372 | nRot | 0 |
Heavy Atom Molecular Weight | 196.164 | nRig | 14 |
Exact Molecular Weight | 222.198 | nRing | 3 |
Solubility: LogS | -4.095 | nHRing | 1 |
Solubility: LogP | 4.731 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 43.1886 |
nHD | 0 | BPOL | 27.8194 |
QED | 0.598 |
Synth | 4.233 |
Natural Product Likeliness | 2.99 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.2 |
Pgp-sub | 0 |
HIA | 0.005 |
CACO-2 | -4.669 |
MDCK | 0.0000136 |
BBB | 0.54 |
PPB | 0.948109 |
VDSS | 2.289 |
FU | 0.0594339 |
CYP1A2-inh | 0.074 |
CYP1A2-sub | 0.706 |
CYP2c19-inh | 0.243 |
CYP2c19-sub | 0.951 |
CYP2c9-inh | 0.192 |
CYP2c9-sub | 0.428 |
CYP2d6-inh | 0.034 |
CYP2d6-sub | 0.596 |
CYP3a4-inh | 0.436 |
CYP3a4-sub | 0.366 |
CL | 9.981 |
T12 | 0.122 |
hERG | 0.016 |
Ames | 0.031 |
ROA | 0.203 |
SkinSen | 0.144 |
Carcinogencity | 0.385 |
EI | 0.04 |
Respiratory | 0.952 |
NR-Aromatase | 0.472 |
Antiviral | Yes |
Prediction | 0.858937 |